ADZENYS XR-ODT
NT0202.1009
Approved small_molecule terminated
Quick answer
ADZENYS XR-ODT for Attention Deficit Hyperactivity Disorder is a Approved program (small_molecule) at AYTU BIOPHARMA, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AYTU BIOPHARMA, INC
- Indication
- Attention Deficit Hyperactivity Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated